Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival.

Literature DB >> 7444826

Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival.

M Turner-Warwick, B Burrows, A Johnson.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1980 PMID： 7444826 PMCID： PMC471341 DOI： 10.1136/thx.35.8.593

Source DB: PubMed Journal: Thorax ISSN： 0040-6376 Impact factor: 9.139

× No keyword cloud information.

6 in total

1. DESQUAMATIVE INTERSTITIAL PNEUMONIA.

Authors: A A LIEBOW; A STEER; J G BILLINGSLEY
Journal: Am J Med Date: 1965-09 Impact factor: 4.965

2. The prognosis of cryptogenic fibrosing alveolitis.

Authors: B H Stack; Y F Choo-Kang; B E Heard
Journal: Thorax Date: 1972-09 Impact factor: 9.139

3. Natural history and treated course of usual and desquamative interstitial pneumonia.

Authors: C B Carrington; E A Gaensler; R E Coutu; M X FitzGerald; R G Gupta
Journal: N Engl J Med Date: 1978-04-13 Impact factor: 91.245

4. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival.

Authors: M Turner-Warwick; B Burrows; A Johnson
Journal: Thorax Date: 1980-03 Impact factor: 9.139

5. Circulating immune complexes in the idiopathic interstitial pneumonias.

Authors: R B Dreisin; M I Schwarz; A N Theofilopoulos; R E Stanford
Journal: N Engl J Med Date: 1978-02-16 Impact factor: 91.245

6. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors: R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal: Br J Cancer Date: 1977-01 Impact factor: 7.640

6 in total

39 in total

Review 1. In search of a cause of cryptogenic fibrosing alveolitis (CFA): one initiating factor or many?

Authors: M Turner-Warwick
Journal: Thorax Date: 1998-08 Impact factor: 9.139

Review 2. Review of cryptogenic fibrosing alveolitis, including current treatment guidelines.

Authors: S C Bourke; H Clague
Journal: Postgrad Med J Date: 2000-10 Impact factor: 2.401

Review 3. The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction.

Authors:
Journal: Thorax Date: 1999-04 Impact factor: 9.139

4. A survey of nocturnal hypoxaemia and health related quality of life in patients with cryptogenic fibrosing alveolitis.

Authors: M Clark; B Cooper; S Singh; M Cooper; A Carr; R Hubbard
Journal: Thorax Date: 2001-06 Impact factor: 9.139

5. High resolution computed tomography as a predictor of lung histology in systemic sclerosis.

Authors: A U Wells; D M Hansell; B Corrin; N K Harrison; P Goldstraw; C M Black; R M du Bois
Journal: Thorax Date: 1992-09 Impact factor: 9.139

Review 6. Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches.

Authors: Moisés Selman; Victor J Thannickal; Annie Pardo; David A Zisman; Fernando J Martinez; Joseph P Lynch
Journal: Drugs Date: 2004 Impact factor: 9.546

7. A critical assessment of treatment options for idiopathic pulmonary fibrosis.

Authors: Nirav R Shah; Paul Noble; Robert M Jackson; Talmadge E King; Steven D Nathan; Maria Padilla; Ganesh Raghu; Melissa Bruce Rhodes; Marvin Schwarz; Gregory Tino; Robert W Dubois
Journal: Sarcoidosis Vasc Diffuse Lung Dis Date: 2005-10 Impact factor: 0.670